The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
The PhRMA Medicines in Development reports are almost hard to read because it’s hard to wrap your head around some of the numbers. The latest from the group looks at
It’s official, folks: Robert Kennedy, Jr. is your new Secretary of HHS. (More on that below.) The next question: how long will he last? I want your guess. Here are the